Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs cocktail vs no local infiltration after arthroscopic rotator cuff repair
ChiCTR2500106659Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in rotator cuff tear and postoperative pain (3 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: Mean VAS pain score at rest at 24, 48, and 72 hours postoperatively. Started Jul 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
rotator cuff tearpostoperative pain
Beyond the preview
Go deeper on ChiCTR2500106659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106659.